Quoin Pharmaceuticals Ltd
Last update: 7:30PM (Delayed 15-Minutes)
Get Real Time Here
Vol / Avg.96.266K / 19.850KMkt Cap4.936M
Day Range5.070 - 5.75052 Wk Range3.640 - 406.080

Quoin Pharmaceuticals Stock (NASDAQ:QNRX), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1


Highest Price Target1


Lowest Price Target1


Consensus Price Target1


Analyst Rating Summary1


Analyst Firms Making Recommendations1

  • Alliance Global Partners
  • Ladenburg Thalmann
  • Maxim Group
  • JMP Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Quoin Pharmaceuticals

Upgrades (0)

Downgrades (0)

Initiations (4)

Buy Now
Current price
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
09/07/2022QNRXBuy Now
Quoin Pharmaceuticals
$5.00300%Alliance Global Partners
James Molloy
→ $240Initiates → BuyGet Alert
05/06/2022QNRXBuy Now
Quoin Pharmaceuticals
$5.00-60%Ladenburg Thalmann
Aydin Huseynov
→ $300Initiates → BuyGet Alert
01/07/2022QNRXBuy Now
Quoin Pharmaceuticals
$5.00Maxim Group
Naz Rahman
→ $750Initiates → BuyGet Alert
12/15/2021QNRXBuy Now
Quoin Pharmaceuticals
$5.0060%JMP Securities
Jason Butler
Initiates → Market OutperformGet Alert

What is the target price for Quoin Pharmaceuticals (QNRX)?


The latest price target for Quoin Pharmaceuticals (NASDAQ: QNRX) was reported by Alliance Global Partners on September 7, 2022. The analyst firm set a price target for $20.00 expecting QNRX to rise to within 12 months (a possible 300.00% upside). 0 analyst firms have reported ratings in the last year.


What is the most recent analyst rating for Quoin Pharmaceuticals (QNRX)?


The latest analyst rating for Quoin Pharmaceuticals (NASDAQ: QNRX) was provided by Alliance Global Partners, and Quoin Pharmaceuticals initiated their buy rating.


When is the next analyst rating going to be posted or updated for Quoin Pharmaceuticals (QNRX)?


Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quoin Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quoin Pharmaceuticals was filed on September 7, 2022 so you should expect the next rating to be made available sometime around September 7, 2023.


Is the Analyst Rating Quoin Pharmaceuticals (QNRX) correct?


While ratings are subjective and will change, the latest Quoin Pharmaceuticals (QNRX) rating was a initiated with a price target of $0.00 to $20.00. The current price Quoin Pharmaceuticals (QNRX) is trading at is $5.00, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.